NewsRoom Articles - Page 134 of 592

WednesdayDec 07, 2022 4:20 pm

420 with CNW — New Applications for Federal Positions Won’t Require Cannabis Use History

More than two decades after California first legalized medical cannabis, dozens of states now have their own medical and recreational cannabis markets. The cannabis industry generates billions of dollars in sales every year, proving that cannabis is one of the most popular drugs in the country even as states have loosened their policies. However, the federal government still considers cannabis a Schedule I controlled substance, meaning that even though qualifying individuals are allowed to take part in state-legal cannabis markets, their actions remain illegal at the federal level. As a result, cannabis consumers often find themselves penalized for purchasing and…

WednesdayDec 07, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Findings of Animal Anti-Seizure Study Program Suggesting that DehydraTECH(TM)-CBD Is More Effective at Lower Doses and Works More Rapidly than FDA-Approved Epidiolex

Lexaria recently announced the findings of the first two studies from its EPIL-A21-1 animal research program The program is designed to assess the effectiveness of patented DehydraTECH(TM)-CBD in reducing or eliminating seizure activity compared to Epidiolex, a CBD-based anti-seizure drug The first study evidenced that DehydraTECH-CBD is more efficacious at lower doses than Epidiolex The second study demonstrated DehydraTECH-CBD’s enhanced effectiveness; specifically, the formulation acted more rapidly than Epidiolex Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced its patented DehydraTECH(TM)-processed cannabidiol (“CBD”) formulation has demonstrated performance enhancements compared to Epidiolex(R), the first and only FDA-approved…

WednesdayDec 07, 2022 4:20 am

420 with CNW — Minnesota Expands List of Qualifying Conditions for Medical Cannabis

The Department of Health in Minnesota has approved the addition of obsessive compulsive disorder (OCD) and irritable bowel syndrome (IBS) to the list of medical conditions for which patients can be certified to start using medical marijuana. This change is slated for implementation starting on Aug. 1, 2023. Jan Malcolm, the state’s health commissioner, said that the health department was adding OCD and IBS to the list of qualifying conditions so that the patients suffering from these two conditions, which are debilitating, could have access to an expanded pool of treatment options to manage their medical conditions. People who suffer…

TuesdayDec 06, 2022 4:20 pm

420 with CNW — Ohio Campaigners Look to 2023 Ballot to Legalize Adult-Use Marijuana

Cannabis reform activists in the state of Ohio are hoping to get a recreational cannabis legalization bill on the November 2023 ballot. Earlier this year, the campaign behind a legalization measure announced that the bill would not be on the 2022 ballot but that there was a chance of getting the measure on the subsequent year’s ballot. The Coalition to Regulate Marijuana Like Alcohol had filed a complaint for declaratory judgment in April to ensure that the measure made it onto last month’s ballot. The suit was unsuccessful, however, and the coalition reached an agreement with legislative leaders and the…

TuesdayDec 06, 2022 4:20 am

420 with CNW — Nevada Conducts Lottery to Select Cannabis Consumption Lounge Licensees

As the Cannabis Control Board of Nevada had earlier announced, regulators held two lotteries on last week to pick the first set of licensees that will be allowed to open marijuana consumption lounges in the state. A total of 40 licenses were awarded during the lotteries. Half of the licenses went to existing marijuana businesses that wished to add consumption lounges to their facilities while the other half went to companies that wished to open standalone cannabis consumption lounges. Of this number, 10 went to social-equity applicants while the remaining 10 went to other applicants that didn’t fall in the…

MondayDec 05, 2022 4:20 pm

420 with CNW — Gallup Data Suggests Young Americans Are More Likely to Use Marijuana Than Tobacco

Cigarette smoking in the United States has been on a decline since 1964 when adult smoking prevalence rates peaked. As the population has become more cognizant of the health risks of smoking, fewer young people have picked up the habit. By 2020, only 13 out of every 100 adults in America (12.5%) smoked regularly. A new report from Gallup has now revealed that young Americans are two times more likely to report smoking cannabis compared to tobacco cigarettes. Gallup analyzed survey data on marijuana and tobacco use among adults from 2001 to 2022, finding that past-week tobacco use by adults…

MondayDec 05, 2022 11:15 am

REZYFi, Inc. Eyes Developing Californian Cannabis Market Amid Approval of Ballot Measures to Expand Retail

California voters recently approved 12 local ballot measures in the 2022 midterm elections to either expand or create cannabis markets in a dozen municipalities These approvals, it is projected, will translate to over 70 new retail licenses and countless other business opportunities for plant-touching and ancillary companies that serve those retailers Having positioned itself as one of the first cannabis mortgage bankers in the United States, REZYFi’s management is confident that these approvals, coupled with the growing conversation around marijuana and its growing expansion into additional states, will significantly strengthen its brand recognition and equity The company looks to accumulate…

MondayDec 05, 2022 4:20 am

420 with CNW — Marijuana Growers Face New Challenges as Washington State Clocks a Decade of Legalization

Voters in Washington state chose to legalize recreational cannabis a decade ago, opening the state up to a multibillion-dollar industry that has seen significant growth in just a few short years. But, even though the adult-use cannabis industry has proven to be quite lucrative with retailers in Washington state selling around $1.5 billion to $1.7 billion worth of cannabis in 2022, the industry is not without its challenges. A decade after legalizing recreational cannabis sales, Washington’s cannabis industry still faces a myriad of problems that have prevented the space from fully realizing its potential. For starters, there is a crippling…

FridayDec 02, 2022 4:20 pm

420 with CNW — Massachusetts Company Creates Marijuana Gummy to Help Weight Loss

Many people tend to connect marijuana to “the munchies” and appetite boosting, but a Wareham, Massachusetts, company is proving that its marijuana edible can not only suppress appetite but also provide an energy boost that will help you coast through your workout session. Coast Cannabis, founded by a husband-and-wife team (Brian Cusick and Angela Brown), makes marijuana gummies that give their consumers an unmistakable energy boost. While speaking about how their unique edible came to be, Brown reveals that she ate the gummy while getting ready to head to the gym and felt a burst of energy that lasted throughout…

FridayDec 02, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Moves Forward With Exploration of Patented DehydraTECH(TM)-Processed CBD for Dementia

Approximately 55 million people worldwide have dementia, which is expected to grow to 78 million by 2030 The dementia treatment market was valued at $13.78 billion in 2021. The market is expected to grow at a CAGR of 8.32%, resulting in a value of $26.13 billion by 2029 Clinical studies have established a connection between hypertension and dementia With DehydraTECH(TM)-CBD already evidencing that it can lower blood pressure and its propensity to cross the blood-brain barrier, Lexaria is investigating the potential for a positive outcome in the DEM-A22-1 study According to the World Health Organization (“WHO”), dementia is the seventh…

News and publishing service for cannabis related companies

Contact us: 512.354.7000